Cargando…

Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma

BACKGROUND: To evaluate the efficacy and toxicity of fractionated stereotactic radiotherapy (FSRT) in patients with residual nasopharyngeal carcinoma (NPC). METHODS: From January 2000 to December 2009, 136 NPC patients with residual lesions after primary radiotherapy (RT) were treated by FSRT. The t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Feng, Xiao, Jian-ping, Xu, Guo-zhen, Gao, Li, Xu, Ying-jie, Zhang, Ye, Jiang, Xue-song, Yi, Jun-lin, Luo, Jing-wei, Huang, Xiao-dong, Huan, Fu-kui, Fang, Hao, Wan, Bao, Li, Ye-xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702464/ https://www.ncbi.nlm.nih.gov/pubmed/23806065 http://dx.doi.org/10.1186/1748-717X-8-157

Ejemplares similares

Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis
por: Chua, Daniel TT, et al.
Publicado: (2009)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
por: Jiang, Xue-song, et al.
Publicado: (2012)

Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT)
por: Combs, Stephanie E, et al.
Publicado: (2006)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Doses, fractionations, constraints for stereotactic radiotherapy
por: Borghesi, Simona, et al.
Publicado: (2022)

Residual intra-fraction error in robotic spinal stereotactic body radiotherapy without immobilization devices
por: Rossi, Eleonora, et al.
Publicado: (2020)

Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone
por: Chen, Xiu-jun, et al.
Publicado: (2011)

Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
por: Elhateer, H., et al.
Publicado: (2008)

Fractionated stereotactic radiotherapy for pediatric patients with retinoblastoma
por: Higgins, Patrick D., et al.
Publicado: (2006)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2017)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma
por: Feng, Xiao-Yao, et al.
Publicado: (2022)

Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer
por: Roeder, Falk, et al.
Publicado: (2011)

Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States
por: P. Weiner, Joseph, et al.
Publicado: (2017)

Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
por: Burgess, Laura, et al.
Publicado: (2020)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Efficacy and Safety of Chemotherapy Combined with Stereotactic Radiotherapy in the Treatment of Nasopharyngeal Carcinoma
por: Shan, Guo-Ping, et al.
Publicado: (2017)

Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis
por: Liang, Zhong Guo, et al.
Publicado: (2018)

The treatment of a large acoustic tumor with fractionated stereotactic radiotherapy
por: McClelland, Shearwood, et al.
Publicado: (2007)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
por: Kalinauskaite, Goda G., et al.
Publicado: (2020)

Stereotactic Radiotherapy with Fractionation for the Lesions in and Around the Brainstem and Optic Nerve
por: Kida, Yoshihisa, et al.
Publicado: (2019)

A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
por: Kawakami, S., et al.
Publicado: (2022)

Effectiveness and Toxicities of Intensity-Modulated Radiotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2013)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
por: Gong, Yining, et al.
Publicado: (2019)

Prognostic factors for survival of patients with nasopharyngeal carcinoma following conventional fractionation radiotherapy
por: KONG, FEI, et al.
Publicado: (2013)

Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
por: Hirata, Masanori, et al.
Publicado: (2022)

Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas
por: Minniti, Giuseppe, et al.
Publicado: (2011)

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy
por: Finazzi, Tobias, et al.
Publicado: (2020)

Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis
por: Layer, Julian P., et al.
Publicado: (2023)

Fractionated stereotactic radiotherapy of brain metastases: results of a retrospective study
por: Gruber, Isabella, et al.
Publicado: (2023)

Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma
por: Combs, Stephanie E, et al.
Publicado: (2007)

Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy
por: Huang, Bao-Tian, et al.
Publicado: (2015)

Treatment of Residual, Recurrent, or Metastatic Intracranial Hemangiopericytomas With Stereotactic Radiotherapy Using CyberKnife
por: Huang, Lichao, et al.
Publicado: (2021)

Six fractions weekly as accelerated fraction radiotherapy: Is it applicable for nasopharyngeal cancer? A review
por: Widikusumo, Arundito, et al.
Publicado: (2019)

Correction: Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
por: Hirata, Masanori, et al.
Publicado: (2023)

Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma after primary radiotherapy: options of surgical methods and regions
por: Wang, Sheng-ye, et al.
Publicado: (2016)

Current Treatment Options for Local Residual Nasopharyngeal Carcinoma
por: Stoker, S. D., et al.
Publicado: (2013)

Adjuvant or radical fractionated stereotactic radiotherapy for patients with pituitary functional and nonfunctional macroadenoma
por: Weber, Damien C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ue3g4em1ebi9rae6opqdvv9g1b